We understand the complexities of navigating the jurisdictional differences in core markets. We offer expert European patent advice to help you and your clients realise your IP strategy. We also strongly believe in future-proofing drafts to ensure multijurisdictional protection is not only achievable, but fully aligned with the commercial strategy. By keeping a finger on the pulse of fast-paced legal developments, we are perfectly positioned to help you navigate European IP challenges and opportunities.
European patent strategy
Europe remains a core market for pharmaceutical companies. As highly experienced European patent attorneys we provide tailored drafting and prosecution strategies aligned with your client’s commercial objectives. Our expertise enables us to recommend approaches for expediting prosecution, minimising expenses, or securing meaningful and robust protection against potential infringements. We excel at navigating the evolving landscape of pharmaceutical IP case law and can guide your clients through recent developments in second medical use, antibodies, polymorph, and cell therapy patenting. Additionally, we offer guidance on managing post-published data, description modifications, and establishing proper basis for claim amendments within the European framework.
European regulatory environment
Patent protection typically forms just one element of your client’s comprehensive market strategy in Europe. We provide insights on the broader regulatory landscape, including EU clinical trial disclosure requirements, Brexit implications, data and market exclusivity periods, and how these mechanisms interact with patent systems throughout Europe to maximise protection and commercial advantage.
